112 related articles for article (PubMed ID: 8175282)
21. Erythropoietin in pregnancies complicated by severe anemia of renal failure.
Yankowitz J; Piraino B; Laifer SA; Frassetto L; Gavin L; Kitzmiller JL; Crombleholme W
Obstet Gynecol; 1992 Sep; 80(3 Pt 2):485-8. PubMed ID: 1495715
[TBL] [Abstract][Full Text] [Related]
22. Complete correction of renal anemia by recombinant human erythropoietin.
Ludat K; Paulitschke M; Riedel E; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human erythropoietin for anaemia associated with chronic renal failure in predialysis patients.
Schaefer RM; Schaefer L; Heidland A
Przegl Lek; 1992; 49(1-2):41-2. PubMed ID: 1455005
[No Abstract] [Full Text] [Related]
24. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
25. Outcome of renal transplantation in patients treated with erythropoietin.
Linde T; Wahlberg J; Wikström B; Danielson BG
Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
27. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
[TBL] [Abstract][Full Text] [Related]
28. [Erythropoietin drugs in patients with chronic renal failure at the stage of conservative treatment. Effectiveness and side effects].
Alekseeva TB; Nikolaev AIu; Dasaeva LA
Ter Arkh; 2000; 72(6):58-60. PubMed ID: 10900653
[TBL] [Abstract][Full Text] [Related]
29. The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis.
Abbas EE; Afioni N; Al Wakeel J; Bakr MA; Dham R; Donia A; Droubi N; Khidir E; Mathew CM; Mitwali AH; Naga S; Pingle A; Rashed A; Roshdy A; Shaheen F; Shaibani B; Shaibani FM; Shaker DS; Sheiban A; Solieman M
Transplant Proc; 2004; 36(6):1805-11. PubMed ID: 15350482
[TBL] [Abstract][Full Text] [Related]
30. [High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].
Xu F; Zhang L; Xiang XJ; Wang ZQ; Zhou ZM; Wang SY
Ai Zheng; 2006 Sep; 25(9):1120-2. PubMed ID: 16965653
[TBL] [Abstract][Full Text] [Related]
31. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
Pizzarelli F; David S; Sala P; Icardi A; Casani A
Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
[TBL] [Abstract][Full Text] [Related]
32. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
[TBL] [Abstract][Full Text] [Related]
34. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
[TBL] [Abstract][Full Text] [Related]
36. Early intervention with recombinant human erythropoietin therapy.
Teehan BP; Benz RL; Sigler MH; Brown JM
Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414
[No Abstract] [Full Text] [Related]
37. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
[TBL] [Abstract][Full Text] [Related]
38. Treatment of renal anemia by subcutaneous erythropoietin in children with preterminal chronic renal failure.
Schärer K; Klare B; Braun A; Dressel P; Gretz N
Acta Paediatr; 1993 Nov; 82(11):953-8. PubMed ID: 8111177
[TBL] [Abstract][Full Text] [Related]
39. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
[No Abstract] [Full Text] [Related]
40. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA
Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
